Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$198,911
+$5,636 QoQ
Shares Held
1,049
+7.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,194
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Penserra Capital Management LLC holds $2,738,678 across 11 Drug Manufacturers - General names. AZN ranks #7 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
833 | $999,123 | |
| 2 | NVO |
Novo Nordisk A S
|
8,881 | $425,755 | |
| 3 | ABBV |
AbbVie Inc.
|
1,197 | $301,212 | |
| 4 | PFE |
Pfizer Inc
|
9,522 | $229,288 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,760 | $226,160 | |
| 6 | AMGN |
Amgen Inc
|
597 | $216,185 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
1,049 | $198,911 | |
| 8 | JNJ |
Johnson & Johnson
|
336 | $85,333 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $198,911 | 1,049 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $193,275 | 980 | Shares | Defined | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||